Intellia Therapeutics
NTLA
NTLA
157 hedge funds and large institutions have $833M invested in Intellia Therapeutics in 2018 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 40 increasing their positions, 53 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
157
Holders Change
+1
Holders Change %
+0.64%
% of All Funds
3.6%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.09%
New
21
Increased
40
Reduced
53
Closed
19
Calls
$3.02M
Puts
$6.49M
Net Calls
-$3.47M
Net Calls Change
-$4.53M
Top Buyers
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
$165M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
$75.9M |
| 3 |
BlackRock
New York
|
$78.5M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
$4.73M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$13.3M |
